Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
96640393 | 9664039 | 3 | F | 20160907 | 20131101 | 20160914 | EXP | US-ALEXION PHARMACEUTICALS INC.-A201302853 | ALEXION | 0.00 | M | Y | 0.00000 | 20160914 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
96640393 | 9664039 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | UNK | U | T3-10008A | 125166 | CONCENTRATE FOR SOLUTION FOR INFUSION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
96640393 | 9664039 | 1 | Haemolytic uraemic syndrome |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
96640393 | 9664039 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
96640393 | 9664039 | Adverse event | |
96640393 | 9664039 | Decreased appetite | |
96640393 | 9664039 | Lethargy | |
96640393 | 9664039 | Nausea | |
96640393 | 9664039 | Vomiting | |
96640393 | 9664039 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |